Home LiteratureArticle Details
PMID: 5100262 Published · ppublish English Journal Article

Prevention of postoperative deep venous thrombosis and pulmonary embolism.

British medical journal ·Vol. 1 ·No. 5744 ·1971-02-06 ·Pages 312-4

Carter AE, Eban R, Perrett RD

Abstract

Two series of patients observed clinically and by phlebography suggest that one agent known to produce a reduction in platelet aggregation in vitro might be useful in reducing the incidence of deep venous thrombosis and pulmonary embolism postoperatively. The agent used in this study was hydroxychlorquine sulphate.

MeSH Terms
Aged Humans
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Carter A E
Eban R
Perrett R D
References (6)
6 references, click to expand
  1. The post-mortem incdence of pulmonary embolism in a hospital population.
    Br J Surg. 1968 May;55(5):347-52 PMID: 5648012
  2. 125-I-labelled fibrinogen in the diagnosis of deep-vein thrombosis and its correlation with phlebography.
    Br J Surg. 1968 Nov;55(11):835-9 PMID: 5688647
  3. Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis.
    Lancet. 1969 Oct 4;2(7623):718-20 PMID: 4186168
  4. THE AGGREGATION OF BLOOD PLATELETS.
    J Physiol. 1963 Aug;168:178-95 PMID: 14056485
  5. PROTHROMBIN-TIME AND THROMBOTEST IN INJURED PATIENTS ON PROPHYLACTIC ANTICOAGULANT THERAPY.
    Lancet. 1964 Jan 18;1(7325):124-9 PMID: 14074476
  6. Use of antimalarial drugs as "desludging" agents in vascular disease processes.
    J Am Med Assoc. 1960 Apr 9;172:1630-3 PMID: 14419689
Article Info
Journal
British medical journal
Abbr.
Br Med J
ISSN
0007-1447
Published
1971-02-06
Pages
312-4
Language
English
Region
England
NLM ID
0372673
PMCID
PMC1794857
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com